Quarterly report pursuant to Section 13 or 15(d)

CONDENSED INTERIM STATEMENTS OF OPERATIONS

v3.24.1.1.u2
CONDENSED INTERIM STATEMENTS OF OPERATIONS - USD ($)
3 Months Ended
Mar. 31, 2024
Mar. 31, 2023
OPERATING EXPENSES    
Research and Development $ 1,555,011 $ 1,015,583
General and Administrative 2,822,878 1,887,374
TOTAL OPERATING EXPENSES 4,377,889 2,902,957
NET LOSS $ (4,377,889) $ (2,902,957)
LOSS PER SHARE    
Basic net loss per common share $ (0.28) $ (0.25)
Diluted net loss per common share $ (0.28) $ (0.25)
Weighted average common shares outstanding basic 15,472,507 11,639,395
Weighted average common shares outstanding diluted 15,472,507 11,639,395